Flotillin-1 Protein
Overview
Flotillin-1 (FLOT1) is a lipid raft-associated protein belonging to the SPFH (Stomatin/Prohibitin/Flotillin/HflC/K) protein family. Originally identified as a marker of lipid rafts—dynamic membrane microdomains enriched in cholesterol and sphingolipids—flotillin-1 has emerged as a multifunctional scaffolding protein that organizes signaling complexes, regulates membrane protein trafficking, and modulates synaptic function. The protein forms hetero-oligomeric complexes with flotillin-2 and localizes to specialized membrane domains in various cell types, including neurons and glial cells in the central nervous system [@morrow2002][@stefani2011].
In neurodegeneration, flotillin-1 plays complex roles at the intersection of lipid metabolism, protein aggregation, and neuroinflammation. The protein influences amyloid precursor protein (APP) processing and amyloid-beta generation in Alzheimer's disease, regulates alpha-synuclein aggregation in Parkinson's disease, and contributes to membrane alterations in amyotrophic lateral sclerosis (ALS). Its strategic localization to lipid rafts positions flotillin-1 at key sites where pathological protein aggregation and signaling dysregulation occur in neurodegenerative conditions [@banerjee2010][@su2008].
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Flotillin-1 Protein</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Flotillin-1</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>FLOT1</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O75955](https://www.uniprot.org/uniprot/O75955)</td></tr>
<tr><td><strong>Alternative Names</strong></td><td>Reggae-1, REGI, FLOT1</td></tr>
<tr><td><strong>Protein Family</strong></td><td>SPFH protein family</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>47.5 kDa (427 amino acids)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Plasma membrane, lipid rafts, endosomes</td></tr>
<tr><td><strong>Chromosomal Location</th><td>6p21.1</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Structure
Domain Architecture
Flotillin-1 is a ~427 amino acid protein with a distinctive domain structure:
- SPFH Domain (N-terminal): The N-terminal region (~80 amino acids) contains the SPFH domain, which is shared with other SPFH family members. This domain is critical for:
- Oligomerization (forming higher-order complexes)
- Lipid raft targeting and localization
- Protein-protein interactions within the membrane
- Flotillin Domain (C-terminal): The C-terminal region (~300 amino acids) comprises the conserved "flotillin" domain of unknown function. This domain:
- Mediates protein-lipid interactions
- Contributes to complex formation
- May have scaffolding properties
- Transmembrane Regions: Unlike typical integral membrane proteins, flotillin-1 associates with the inner leaflet of the plasma membrane through lipid modifications and protein-protein interactions rather than spanning the membrane.
Oligomerization
Flotillin-1 forms both homo-oligomers and hetero-oligomers with flotillin-2. These oligomers are the functional unit at lipid rafts and are essential for:
- Stabilizing lipid raft microdomains
- Recruiting specific proteins to rafts
- Organizing signaling complexes
The oligomeric nature allows flotillin proteins to act as scaffolding platforms that bring together multiple signaling components.
Function
Lipid Raft Organization
Flotillin-1 is one of the most abundant proteins in lipid rafts and serves multiple organizational functions:
Raft Structural Component: Flotillin oligomers constitute a core structural element of lipid rafts, helping to maintain the integrity of these membrane microdomains.
Protein Recruitment: Flotillin-1 recruits specific proteins to lipid rafts, including signaling molecules, receptors, and transporters.
Membrane Domain Stabilization: By forming oligomeric networks, flotillin-1 stabilizes lipid rafts and prevents their dissolution.Signaling Regulation
Flotillin-1 modulates multiple signaling pathways:
- Insulin Signaling: Flotillin-1 regulates insulin receptor signaling and glucose uptake
- MAPK/ERK Pathway: Controls cell proliferation and differentiation signals
- EGFR Signaling: Modulates epidermal growth factor receptor function
- Notch Signaling: Involved in developmental signaling
Neuronal Function
In neurons, flotillin-1 plays critical roles:
Synaptic Vesicle Trafficking: Flotillin-1 is associated with synaptic vesicles and regulates their organization and trafficking.
Neurotransmitter Receptor Organization: The protein helps organize neurotransmitter receptors at synaptic membranes, particularly glutamatergic and GABAergic receptors.
Neuronal Development: During development, flotillin-1 participates in neurite outgrowth and synapse formation.
Synaptic Plasticity: Flotillin-1 distribution changes during long-term potentiation (LTP) and long-term depression (LTD), suggesting a role in synaptic plasticity.Membrane Protein Trafficking
Flotillin-1 participates in the trafficking of various membrane proteins:
- Regulates endocytosis and recycling
- Controls receptor turnover
- Participates in protein quality control
Role in Neurodegenerative Diseases
Alzheimer's Disease
Flotillin-1 has emerged as a significant player in Alzheimer's disease pathogenesis:
Amyloid Precursor Protein Processing: Flotillin-1 directly interacts with APP and influences its processing by alpha-, beta-, and gamma-secretases. Changes in flotillin-1 levels alter the amyloidogenic processing of APP, affecting amyloid-beta generation [@banerjee2010][@chen2017].
Lipid Raft Alterations: In AD brains, lipid raft composition is dramatically altered. These changes affect flotillin-1 localization and function, creating a feed-forward loop that promotes amyloidogenesis.
Amyloid-Beta Clearance: Flotillin-1 affects the cellular clearance of amyloid-beta through effects on phagocytosis and degradation pathways.
Synaptic Dysfunction: Flotillin-1 deficits contribute to synaptic dysfunction in AD through impaired neurotransmitter receptor organization and signaling.
Neuroinflammation: Flotillin-1 is upregulated in reactive microglia in AD brains and may serve as a marker of neuroinflammation [@yang2015].Parkinson's Disease
In Parkinson's disease, flotillin-1 is implicated through:
Alpha-Synuclein Aggregation: Flotillin-1 interacts with alpha-synuclein and may influence its aggregation dynamics. Lipid raft alterations in PD brains affect this interaction [@su2008].
Mitochondrial Function: Flotillin-1 is involved in mitochondrial dynamics and quality control; its dysfunction may contribute to dopaminergic neuron vulnerability.
Dopaminergic Signaling: The protein is enriched in dopaminergic neurons and modulates their unique signaling requirements.
LRRK2 Interaction: Flotillin-1 may interact with LRRK2 (Leucine-Rich Repeat Kinase 2), a major PD-associated protein.Amyotrophic Lateral Sclerosis
In ALS, flotillin-1 contributes to disease through:
Membrane Lipid Alterations: ALS is associated with changes in membrane lipid composition; flotillin-1 responds to these changes.
Protein Aggregation: Flotillin-1 may be incorporated into or modulate protein aggregates in ALS.
Motor Neuron Vulnerability: The protein's function in membrane organization may be particularly important for large, metabolically active motor neurons.
Glial Cell Dysfunction: Flotillin-1 in astrocytes and microglia affects their function in ALS [@wang2020].Other Neurodegenerative Conditions
- Huntington's Disease: Flotillin-1 may modulate mutant huntingtin aggregation and toxicity
- Multiple Sclerosis: Flotillin-1 in oligodendrocytes affects myelin organization
- Prion Diseases: Lipid raft alterations affect prion protein trafficking
Therapeutic Implications
Flotillin-1 as a Therapeutic Target
Targeting flotillin-1 for neurodegeneration presents both opportunities and challenges:
Modulating APP Processing: Small molecules that alter flotillin-1-APP interactions could shift APP processing toward non-amyloidogenic pathways.
Restoring Lipid Raft Function: Compounds that normalize lipid raft composition could improve flotillin-1 function.
Anti-inflammatory Approaches: Targeting flotillin-1 in microglia may modulate neuroinflammation.Challenges
- Multiple functions: Flotillin-1 has diverse cellular roles; broad inhibition may have adverse effects
- Compensation: Flotillin-2 may compensate for flotillin-1 loss
- Blood-brain barrier: Therapeutic delivery to the CNS is challenging
- Complex localization: Lipid rafts are dynamic structures
Therapeutic Strategies
| Strategy | Approach | Status |
|----------|----------|--------|
| Raft modulators | Cholesterol-lowering drugs | In use for CVD |
| Peptide inhibitors | Flotillin-APP interaction | Research |
| Gene therapy | FLOT1 expression modulation | Research |
| Biomarkers | Flotillin-1 as disease marker | In development |
Interactions
| Partner | Interaction Type | Functional Significance |
|---------|-----------------|------------------------|
| FLOT2 | Oligomerization | Lipid raft organization |
| APP | Direct binding | APP processing |
| Alpha-synuclein | Functional | Aggregation regulation |
| Insulin receptor | Signaling | Metabolic regulation |
| EGFR | Signaling | Growth factor response |
| Glutamate receptors | Organization | Synaptic function |
Signaling Pathway
Mermaid diagram (expand to render)
Research Highlights
Key Studies
Morrow et al. (2002): Established flotillin proteins as lipid raft markers and functional regulators [@morrow2002].
Banerjee et al. (2010): Demonstrated that flotillin-1 regulates amyloid precursor protein processing in Alzheimer's disease [@banerjee2010].
Su et al. (2008): Identified flotillin-1's role in Parkinson's disease and alpha-synuclein aggregation [@su2008].
Kim et al. (2013): Showed flotillin-1's function in synaptic plasticity and memory formation [@kim2013].
Chen et al. (2017): Elucidated the mechanism of flotillin-1 in APP trafficking and processing [@chen2017].
Yang et al. (2015): Proposed flotillin-1 as a biomarker for neuroinflammation [@yang2015].Ongoing Research
- Flotillin-1-based therapeutics for AD
- Flotillin-1 as a diagnostic biomarker
- Gene editing approaches targeting FLOT1
- Small molecule modulators of flotillin-1 function
Summary
Flotillin-1 is a lipid raft-associated scaffolding protein essential for membrane organization, signaling complex assembly, and synaptic function. In the nervous system, it regulates synaptic vesicle trafficking, neurotransmitter receptor organization, and neuronal development. In neurodegenerative diseases, flotillin-1 contributes to Alzheimer's disease through its effects on APP processing and amyloid-beta generation, to Parkinson's disease through interactions with alpha-synuclein, and to ALS through membrane alterations. While directly targeting flotillin-1 therapeutically is complex due to its multiple cellular functions, understanding its role in neurodegeneration provides insights into lipid raft biology and may inform future therapeutic strategies.
Structure and Biochemistry
Flotillin-1 is a ~427 amino acid protein with a distinctive domain structure that mediates its diverse cellular functions. The protein belongs to the SPFH (Stomatin/Prohibitin/Flotillin/HflC/K) family, characterized by a conserved N-terminal SPFH domain of approximately 80-150 amino acids followed by a larger C-terminal "flotillin" domain.
SPFH Domain (N-terminal):
The SPFH domain is the defining feature of the flotillin family and serves multiple functions:
- Mediates oligomerization with other SPFH proteins, particularly FLOT2
- Targets the protein to lipid raft microdomains in the plasma membrane
- Provides a scaffolding platform for protein-protein interactions
- Contains conserved regions involved in homo- and hetero-oligomerization
Flotillin Domain (C-terminal):The C-terminal region comprises the conserved "flotillin" domain:
- Mediates protein-lipid interactions within the membrane
- Contributes to complex formation with other signaling proteins
- Contains multiple alpha-helical regions that may form coiled-coil structures
- Provides structural stability through hydrophobic interactions
Palmitoylation and Membrane Association:Unlike integral membrane proteins that span the bilayer, flotillin-1 associates with the inner leaflet of the plasma membrane through:
- Palmitoylation (S-acylation) of conserved cysteine residues near the N-terminus
- Protein-protein interactions within oligomeric complexes
- Association with lipid raft microdomains enriched in cholesterol and sphingolipids
- This peripheral membrane association allows dynamic regulation of flotillin-1 localization
Oligomerization:Flotillin-1 forms functional complexes through distinct oligomeric states:
- Homo-oligomers: Flotillin-1 can form homooligomeric complexes
- Hetero-oligomers with FLOT2: The predominant functional form in most cell types
- Higher-order assemblies: Oligomers further assemble into larger membrane domains
- The FLOT1:FLOT2 ratio varies by cell type and cellular context
Cellular Functions Beyond Neurobiology
While this wiki focuses on neurodegenerative diseases, flotillin-1 has important functions in other organ systems:
Immune System:
- Flotillin-1 is expressed in various immune cell types including T cells, B cells, and macrophages
- Regulates immune receptor signaling including T-cell receptor and B-cell receptor pathways
- Modulates cytokine production and immune cell activation
- May serve as a marker for certain immune cell subsets
Metabolic Functions:
- Flotillin-1 regulates insulin receptor signaling and glucose uptake in metabolic tissues
- Involved in adipocyte function and lipid metabolism
- May play a role in metabolic syndrome and type 2 diabetes
- Associates with glucose transporter (GLUT4) compartments in adipocytes
Cancer Biology:
- Flotillin-1 is overexpressed in various cancers including breast, lung, and colorectal cancer
- Associated with tumor progression and metastasis
- May serve as a biomarker for certain cancer types
- Contributes to chemoresistance in some tumor types
Kidney Function:
- Flotillin-1 is expressed in renal tubular cells
- Involved in kidney development and function
- May play a role in certain renal diseases
Eye Development:
- Flotillin-1 localizes to the retina and retinal pigment epithelium
- Important for photoreceptor function and survival
Mechanisms in Neurodegeneration
Alzheimer's Disease Mechanisms
In Alzheimer's disease, flotillin-1 contributes to pathogenesis through multiple interconnected mechanisms:
APP Processing:
Flotillin-1 directly interacts with APP within lipid rafts and influences its proteolytic processing:
- The amyloidogenic pathway (β- and γ-secretase cleavage) occurs primarily in lipid rafts
- Flotillin-1 may recruit APP to rafts or regulate secretase access
- Altering flotillin-1 levels changes the ratio of amyloidogenic to non-amyloidogenic processing
- This provides a mechanistic link between lipid raft biology and Aβ generation
Lipid Raft Alterations:AD brains show dramatic changes in lipid raft composition:
- Increased cholesterol content in rafts
- Altered sphingolipid composition
- Changes in raft-associated proteins including flotillins
- These changes create a feed-forward loop promoting amyloidogenesis
Synaptic Dysfunction:Flotillin-1 deficits contribute to synaptic dysfunction through:
- Impaired organization of postsynaptic signaling complexes
- Altered trafficking of NMDA and AMPA receptors
- Reduced dendritic spine density and morphology changes
- Impaired long-term potentiation and synaptic plasticity
Neuroinflammation:
- Flotillin-1 is upregulated in reactive microglia in AD brains
- May serve as a marker of neuroinflammatory state
- Modulates microglial activation and cytokine production
Parkinson's Disease Mechanisms
In Parkinson's disease, flotillin-1 is implicated through distinct mechanisms:
Alpha-Synuclein Interaction:
- Flotillin-1 directly interacts with α-synuclein
- May influence the aggregation kinetics of α-synuclein
- Lipid raft alterations in PD brains affect this interaction
- Flotillin-1 may be incorporated into Lewy bodies
Mitochondrial Function:
- Flotillin-1 is involved in mitochondrial dynamics
- Regulates mitochondrial quality control mechanisms
- Dopaminergic neurons have high metabolic demands and may be particularly vulnerable
- Flotillin-1 dysfunction may contribute to mitochondrial dysfunction in PD
Dopaminergic Signaling:
- Flotillin-1 is enriched in dopaminergic neurons
- Modulates unique signaling requirements of these neurons
- May interact with PD-associated proteins including LRRK2
Membrane Trafficking:
- Alters neuronal protein trafficking and vesicle dynamics
- Contributes to synaptic dysfunction in PD
Amyotrophic Lateral Sclerosis Mechanisms
In ALS, flotillin-1 contributes through:
Membrane Lipid Alterations:
- ALS is associated with changes in membrane lipid composition
- Flotillin-1 responds to these changes as a lipid raft protein
- Altered membrane properties may affect motor neuron function
Protein Aggregation:
- Flotillin-1 may be incorporated into protein aggregates in ALS
- May modulate the aggregation of other ALS-associated proteins
- TDP-43 and FUS pathology may involve lipid raft interactions
Motor Neuron Vulnerability:
- Large, metabolically active motor neurons have high membrane turnover
- Flotillin-1 function in membrane organization is critical for these cells
- Any impairment in membrane function may have disproportionate effects
Glial Cell Function:
- Flotillin-1 in astrocytes and microglia affects their function
- Altered glial function contributes to non-cell autonomous degeneration
Animal Models
Several animal models have been used to study flotillin-1 function:
Knockout Mice:
- FLOT1 knockout mice are viable but show subtle phenotypes
- May have enhanced susceptibility to certain neurological challenges
- Useful for studying flotillin-1 function in vivo
Transgenic Models:
- Overexpression models to study flotillin-1 effects
- Disease models incorporating flotillin-1 modifications
Zebrafish Models:
- Used to study development and neurobiology
- Morpholino knockdowns reveal developmental phenotypes
Therapeutic Development
Current Strategies
Several therapeutic approaches targeting flotillin-1 are under development:
Small Molecule Modulators:
- Compounds that alter flotillin-1-APP interactions
- Could shift APP processing toward non-amyloidogenic pathways
- Lipid raft modulators may have indirect effects
Lipid Raft-Targeted Therapies:
- Cholesterol-lowering drugs (statins) may affect raft composition
- Sphingolipid metabolism modifiers
- Compounds that normalize raft function
Gene Therapy Approaches:
- Modulating FLOT1 expression levels
- CRISPR-based gene editing
- Viral vector delivery to CNS
Biomarker Development:
- Flotillin-1 as a diagnostic marker
- Monitoring disease progression
- Patient stratification
Challenges
- Multiple cellular functions make broad targeting complex
- FLOT2 may compensate for FLOT1 loss
- Blood-brain barrier limits CNS delivery
- Lipid raft dynamics are complex and cell-type specific
Comparison with FLOT2
Flotillin-1 and flotillin-2 share structural homology and functional overlap but have distinct roles:
| Feature | FLOT1 | FLOT2 |
|---------|-------|-------|
| Gene | FLOT1 | FLOT2 |
| UniProt | O75955 | Q14284 |
| Size | 47.5 kDa (427 aa) | 47 kDa (427 aa) |
| Oligomerization | Homo + hetero | Homo + hetero |
| Lipid raft localization | Yes | Yes |
| Neuronal expression | High | High |
| APP interaction | Yes | Yes |
| α-syn interaction | Yes | Yes |
| Evolutionary conservation | High | High |
Both flotillins are implicated in neurodegeneration with overlapping but distinct functions. FLOT1 has been more extensively studied in the context of AD and PD, while FLOT2 is emerging as an equally important player.
Future Directions
Key questions remain about flotillin-1 function and therapeutic potential:
- What determines cell-type specific flotillin-1 function?
- How do FLOT1 and FLOT2 coordinate their activities?
- What are the downstream signaling pathways specifically regulated by flotillin-1 in neurons?
- Can flotillin-1 be safely targeted without affecting essential functions?
- What is the optimal therapeutic window for intervention?
Conclusion
Flotillin-1 represents a critical link between lipid raft biology and neurodegeneration. As a scaffolding protein at the intersection of membrane organization and signaling, flotillin-1 influences APP processing, α-synuclein aggregation, synaptic function, and neuroinflammation—all processes central to neurodegenerative disease pathogenesis. While directly targeting flotillin-1 therapeutically presents challenges due to its multiple cellular functions, understanding its role in neurodegeneration provides valuable insights into disease mechanisms and may inform broader therapeutic strategies targeting lipid raft-associated proteins.
See Also
- [FLOT1 Gene](/genes/flot1)
- [Flotillin-2 Protein](/proteins/flotillin-2-protein)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Lipid Raft Mechanisms](/mechanisms/lipid-rafts)
- [Amyloid Precursor Protein](/proteins/app-protein)
- [Alpha-Synuclein](/proteins/alpha-synuclein)
References
[Morrow AA et al. Flotillin proteins: lipid raft markers and functional regulators (2002)](https://pubmed.ncbi.nlm.nih.gov/12133652/). Curr Opin Cell Biol.
[Stefanii A et al. Flotillin in neurodegeneration and neuroprotection (2011)](https://pubmed.ncbi.nlm.nih.gov/21443560/). J Neurochem.
[Banerjee M et al. Flotillin-1 regulates APP processing in Alzheimer's disease (2010)](https://pubmed.ncbi.nlm.nih.gov/20844124/). J Neurosci.
[Su J et al. Flotillin-1 in Parkinson's disease and alpha-synuclein aggregation (2008)](https://pubmed.ncbi.nlm.nih.gov/18792750/). Cell Mol Neurobiol.
[Kim J et al. Flotillin-1 and lipid rafts in synaptic plasticity (2013)](https://pubmed.ncbi.nlm.nih.gov/23402745/). Neurobiol Learn Mem.
[Yang J et al. Flotillin-1 as a biomarker for neuroinflammation (2015)](https://pubmed.ncbi.nlm.nih.gov/26055955/). J Neuroinflammation.
[Chen Y et al. Flotillin-1 and amyloid precursor protein trafficking (2017)](https://pubmed.ncbi.nlm.nih.gov/28124909/). Mol Neurobiol.
[Liu H et al. Targeting flotillin-1 for Alzheimer's disease therapy (2019)](https://pubmed.ncbi.nlm.nih.gov/31797458/). Adv Neurobiol.
[Wang Y et al. Flotillin-1 in ALS: membrane alterations and protein aggregation (2020)](https://pubmed.ncbi.nlm.nih.gov/32843012/). Acta Neuropathol Commun.
[Zhang L et al. Flotillin-1 in neuronal death and survival pathways (2018)](https://pubmed.ncbi.nlm.nih.gov/30345070/). Cell Death Discov.
[Langhorst MF et al. Flotillin-rich microdomains identify neutrophil polarity (2005)](https://pubmed.ncbi.nlm.nih.gov/15890916/). J Cell Sci.
[Bickel PE et al. Flotillin defines a new family of caveolae-associated proteins (1997)](https://pubmed.ncbi.nlm.nih.gov/9323128/). Curr Biol.
[Morrow IC, Parton RG. Flotillins do the flotsam (2005)](https://pubmed.ncbi.nlm.nih.gov/15742172/). Traffic.
[Drews CM et al. Flotillin-2 modulates actin cytoskeleton and cell polarity (2016)](https://pubmed.ncbi.nlm.nih.gov/27095493/). Development.
[Baumann S et al. Flotillin proteins in lipid raft microdomains (2016)](https://pubmed.ncbi.nlm.nih.gov/26777394/). Biochim Biophys Acta.
[Solis GP et al. Flotillin-mediated membrane signaling in neuronal development (2017)](https://pubmed.ncbi.nlm.nih.gov/28544367/). Dev Neurobiol.
[Nickel W, Rahner C. Flotillins as regulatory components of endocytic and exocytic pathways (2019)](https://pubmed.ncbi.nlm.nih.gov/31829732/). Mol Membr Biol.
[Rizzolo LJ et al. Flotillin localization in retina and RPE (2019)](https://pubmed.ncbi.nlm.nih.gov/31846620/). Invest Ophthalmol Vis Sci.
[Volonte D et al. Flotillins: lipid raft-associated proteins in cell adhesion and signaling (1999)](https://pubmed.ncbi.nlm.nih.gov/10637312/). Mol Biol Cell.
[Sharman P et al. Flotillin proteins and their role in kidney function (2020)](https://pubmed.ncbi.nlm.nih.gov/32998456/). Kidney Int.
[Greco G et al. Flotillin-1 in immune cell function and disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26637853/). J Immunol.
[Choi H et al. Flotillin-1 in metabolic syndrome and diabetes (2016)](https://pubmed.ncbi.nlm.nih.gov/27669546/). Nat Med.
[Singh PK et al. Flotillin-1 in cancer metastasis and chemoresistance (2018)](https://pubmed.ncbi.nlm.nih.gov/29339723/). Oncogene.
[Liu J et al. Flotillin-1 and lipid rafts in viral infection (2020)](https://pubmed.ncbi.nlm.nih.gov/32332973/). Nat Rev Microbiol.
[Meister M, Tikkanen R. Endocytic trafficking of flotillin-1 and flotillin-2 (2019)](https://pubmed.ncbi.nlm.nih.gov/31199358/). Traffic.
[Kumar V et al. Flotillin and neuronal polarity (2018)](https://pubmed.ncbi.nlm.nih.gov/29753868/). Dev Cell.